Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2007
09/13/2007WO2007102432A1 Method for producing glycoprotein composition
09/13/2007WO2007102402A1 Method of diagnosing chronic fatigue syndrome
09/13/2007WO2007102400A1 Apparatus for real-time detection of nucleic acid amplification product
09/13/2007WO2007102372A1 Method for reconstitution of proteasome
09/13/2007WO2007102355A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof
09/13/2007WO2007102346A1 Plant having reduced lignin and cellulose contents without reducing glucan content, method of producing the same and utilization thereof
09/13/2007WO2007102240A1 Oasis gene-deficient mouse
09/13/2007WO2007102230A1 Humanized anti-cd20 monoclonal antibody
09/13/2007WO2007102200A1 Anti-cd20 monoclonal antibody
09/13/2007WO2007102146A2 Methods and compositions for identifying a cell phenotype
09/13/2007WO2007102140A2 A semliki forest virus replication competent vector with enhanced biosafety
09/13/2007WO2007102006A2 Non-cloning vector method for generating genomic templates for cluster formation and sbs sequencing
09/13/2007WO2007101949A2 Human interferon-gamma (infgamma) variants
09/13/2007WO2007101867A1 PROCESS FOR THE PRODUCTION OF β-LYSINE
09/13/2007WO2007101678A2 Methods for increasing shoot-to-root ratio, seed production and resistance to diseases
09/13/2007WO2007087492A3 Methods and compositions for modulating tocopherol and tocotrienol content in plants
09/13/2007WO2007084294A3 Epsps mutants
09/13/2007WO2007075592A9 Materials and methods for treating chronic fibrotic disease
09/13/2007WO2007071692A3 Immunogenic composition
09/13/2007WO2007067981A3 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/13/2007WO2007064724A3 Plants having improved growth characteristics and methods for making the same
09/13/2007WO2007058939A3 Identification of usa300 community-associated methicillin-resistant staphylococcus aureus
09/13/2007WO2007047951A3 Molecular delivery to cells using aspirin-related compounds
09/13/2007WO2007041438A3 Compositions comprising glycerophosphodiester phosphodiesterase (gde) and uses thereof
09/13/2007WO2007039070A3 Polynucleotides of haemophilus parasuis and its use
09/13/2007WO2007036945A3 Hepatocyte growth factor receptor splice variants and methods of using same
09/13/2007WO2007035518A3 Aptamers as agonists
09/13/2007WO2007034527A3 snRNA GENE-LIKE TRANSCRIPTIONAL UNITS AND USES THEREOF
09/13/2007WO2007028084A3 Method and molecular diagnostic device for detection, analysis and identification of genomic dna
09/13/2007WO2007019190A3 Role of gax in alzheimer neurovascular dysfunction
09/13/2007WO2007015771A3 Composition and method for introduction of rna interference sequences into targeted cells and tissues
09/13/2007WO2006121579A3 Targeted gene addition in stem cells
09/13/2007WO2006113643A3 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies
09/13/2007WO2006101584A3 Cellulases, nucleic acids encoding them and methods for making and using them
09/13/2007WO2006096989A3 Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the gly-gly-ala domain for enhanced transient gene expression
09/13/2007WO2006084217A3 Rnai-mediated inhibition of ocular hypertension targets
09/13/2007WO2005085448A8 Canine ghrh gene, polypeptides and methdos of use
09/13/2007WO2005062780A3 In vivo odorant receptor systems and their uses
09/13/2007WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/13/2007WO2000061614A8 Uncoupling proteins
09/13/2007US20070214521 Role of microRNA in plant salt tolerance
09/13/2007US20070214520 wound closure or coverage systems, comprising employing the recombinant spider silk protein; artificial cartilage, tendon materials, automotive parts or parts used in the aircraft construction, which comprise the protein
09/13/2007US20070214519 Having gene encoding enzyme that can transfer fucose residue to reducing terminal of acetylglucosamine residue of glycoprotein sugar chain
09/13/2007US20070214518 Viral vectors useful in soybean and methods of use
09/13/2007US20070214517 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
09/13/2007US20070214516 Soybean Seed And Oil Compositions And Methods of Making Same
09/13/2007US20070214515 Polynucleotide encoding a maize herbicide resistance gene and methods for use
09/13/2007US20070214514 Provides X-ray sensitive indicator that can be easily attached to baggage and provides instantaneous confirmation that items have been passed through X-ray screening machine; X-ray sensitive material undergoes chromatic change upon X-ray exposure and not upon other forms of exposure such as uv exposure
09/13/2007US20070214513 Celery cultivar ADS-12
09/13/2007US20070214512 Vector for genetically modifying non-human animals
09/13/2007US20070214511 Transgenic Bird And Method Of Constructing The Same
09/13/2007US20070213521 siRNA targeting cell division cycle 25 (CDC25C)
09/13/2007US20070213520 siRNA targeting calcium/calmodulin dependent protein kinase IV (CAMK4)
09/13/2007US20070213519 Building Block Forming A C=C Double Bond Upon Reaction
09/13/2007US20070213518 polypeptide having lipolytic activity; used as detergent enzymes to remove lipid or fatty stains from clothes and other textiles; exhibit improved performance
09/13/2007US20070213312 Hif-1 Inhibitors and Methods of Use Thereof
09/13/2007US20070213293 Rnai therapeutic for respiratory virus infection
09/13/2007US20070213291 Therapeutically useful synthetic oligonucleotides
09/13/2007US20070213289 Method for purifying plasmid DNA
09/13/2007US20070213287 Introducing nucleic acid encoding therapeutic gene product formulated with an anionic polymer selected from polyglutamic acid, polyaspartic acid, polygalacturonic acid, poly vinyl sulfate into cell
09/13/2007US20070213284 Method of selecting targets for gene silencing by RNA interference
09/13/2007US20070213273 Using hedgehog protein as therapeutic for treatment of bone, reproductive, nervous system and autoimmune disorders
09/13/2007US20070213271 Composition and method for treating hiv infection
09/13/2007US20070213256 Novel genes and proteins encoded thereby
09/13/2007US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes
09/13/2007US20070213253 Synuclein Mutant Having Aggregation-Inhibitory Activity
09/13/2007US20070213249 EGVI endoglucanase and nucleic acids encoding the same
09/13/2007US20070212788 Methods for detecting modulators of cytokine receptor zalpha11
09/13/2007US20070212783 Improving transfer of plasmids/nucleotide sequences into escherichia; mixing a plasmid DNA with the competent cells suspending within ionic solution to form a mixture, plating the mixture on a warm selective medium, and culturing the mixture on the medium
09/13/2007US20070212782 High Density Growth of T7 Expression Strains with Auto-Induction Option
09/13/2007US20070212781 Method for obtaining new life forms
09/13/2007US20070212780 Intron double stranded RNA constructs and uses thereof
09/13/2007US20070212779 Targeting adenoviral vectors to dendritic cells
09/13/2007US20070212769 Transfection, culturing; electrophoresis
09/13/2007US20070212762 Vectors for directional cloning
09/13/2007US20070212760 osmoprotectant selected from 2-methyl-4-carboxy-5-hydroxy-3,4,5,6-tetrahydropyrimidine (THP (A)), 2-methyl-4-carboxy-3,4,5,6-tetrahydropyrimidine (THP (B)) and proline effective for lowering the melting temperature of double stranded DNA; cycled primer extension on a DNA template
09/13/2007US20070212757 Expression System for the B Subunit of Cholera Toxin
09/13/2007US20070212755 Novel Sequence for Improving Expression of Nucleic Acid
09/13/2007US20070212753 Altered antibodies and their preparation
09/13/2007US20070212737 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders
09/13/2007US20070212728 32263, a novel human biotin enzyme and uses thereof
09/13/2007US20070212727 Microorganisms for therapy
09/13/2007US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
09/13/2007US20070212711 P1-34 Expression Units
09/13/2007US20070212707 Cell cycle markers
09/13/2007US20070212706 Novel alkaline proteases and detergents and cleaners comprising these novel alkaline proteases
09/13/2007US20070212705 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity
09/13/2007US20070212699 Process for high throughput DNA methylation analysis
09/13/2007US20070212693 Factor reca from bacillus licheniformis and reca-inactivated safety stems used for biotechnological production
09/13/2007US20070212692 Generation Of Recombinant Genes In Prokaryotic Cells By Using Two Extrachromosomal Elements
09/13/2007US20070212675 Flap Endonuclease (Fen1) Regulatory Sequences And Uses Thereof
09/13/2007US20070212423 Stem cells that transform to beating cardiomyocytes
09/13/2007US20070212404 Liposome And Method Of Preparing The Same
09/13/2007US20070212377 Viral particle comprising nucleotide sequences coding gB gene of infectious laryngotracheitis virus for use in generation of vaccine to prevent respiratory system disorders
09/13/2007US20070212375 Process For Producing In Yeast Empty Viral Capsids Consisting Of Proteins Derived From Pvp2 Of The Infectious Bursal Disease Virus (Ibdv)
09/13/2007US20070212374 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus l1 proteins, and uses thereof
09/13/2007US20070212370 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
09/13/2007US20070212369 Colon Specific Genes and Proteins
09/13/2007US20070212368 Proteins
09/13/2007US20070212347 Compositions and methods for treating polycystic kidney disease gene
1 ... 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 ... 4023